Meet the iQue® 5: Next-Generation HTS Cytometry by Sartorius
Published: 12 Mar 2026
Author: Precedence Research
Sartorius, a life sciences company, has launched the iQue® 5 High-Throughput Screening (HTS) Cytometer, which transforms workflows by providing unmatched flexibility and detailed analysis at high speeds. Building on the established strengths of the iQue® as the top choice for HTS applications, the iQue® 5 expands experimental possibilities with up to 27 channels and customizable workflows in both 96- and 384-well formats.
Accelerate Discovery with the New iQue® 5 HTS Cytometer
"For researchers aiming for the next major breakthrough in antibody or cell therapy, speed is crucial, and no device can rival the speed of the iQue® HTS Platform," says Jonah Riddell, Product Manager of iQue® HTS Systems at Sartorius. "With the iQue® 5, we are offering the most powerful screening capabilities for modern applications, featuring improved software, individual gain settings, and streamlined extended operation, allowing scientists to accomplish more in less time."
According to Precedence Research, the High Throughput Screening (HTS) Market size accounted for USD 25.55 billion in 2025 and is predicted to increase from USD 28.30 billion in 2026 to approximately USD 71.11 billion by 2035, expanding at a CAGR of 10.78% from 2026 to 2035 driven by growing prevalence of chronic diseases, demand for personalized medicine, and technological advancements like 3D cell culture.
Sartorius iQue® 5: Unmatched Speed and Flexibility in Flow Cytometry
This next-generation device has been redesigned to ease workflow challenges, using advanced software to support continuous operation for up to 24 hours without manual input. During experiments, a newly added automated clog detection system reduces downtime, while the integrated Forecyt® software improves the entire process with pre-defined templates and sophisticated analytical tools designed for complex datasets.
"In traditional flow cytometry, resolving clogs can take over an hour, which significantly affects laboratory efficiency," Riddell notes. "The iQue® 5 addresses the clogging issue through several innovations. First, its improved fluidics decrease the overall chance of clogs. Second, automatic detection alerts the user and pauses the experiment when needed. To provide extra assurance, a light indicator gives visual confirmation that the flow is running smoothly.”
With the launch of iQue® 5, Sartorius enhances researchers' ability to accelerate discovery.
A recent report by Precedence Research highlights that the High Throughput Screening (HTS) Market is benefiting from the urgent need to accelerate drug discovery, rising R&D investments in pharmaceuticals, and the adoption of automation and AI to reduce costs.